Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.
News
Influenza vaccination modestly reduces risk of hospitalizations in patients with COPD
News
Investigators use ARMSS score to predict future MS-related disability
News
Continuation of natalizumab treatment reduces risk of MS relapses during pregnancy
News
Many institutions exceed recommended radiation doses during lung cancer screening
News
Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomide
News
Average daily step count reflects disability in MS
News
Ponesimod reduces annualized relapse rate, compared with teriflunomide
News
Continuous treatment reduces risk of confirmed disability progression in MS
News
How does diet affect the risk of IBD?
News
How does diet affect the risk of IBD?
News
Diagnosis and management of gastroparesis and functional dyspepsia pose challenges
News
Is serum serotonin level associated with risk of seizure-related breathing dysfunction?
News
Diagnosis and management of gastroparesis and functional dyspepsia pose challenges
News
What is the best treatment for mast cell activation syndrome?
News
